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Abstract
Bowel inflammatory fibrosis has been largely investigated, but an integrated assessment of remodelling in inflamed colon is lacking. This study
evaluated tissue and cellular changes occurring in colonic wall upon induction of colitis, with a focus on neuromuscular compartment. Colitis
was elicited in rats by 2,4-dinitrobenzenesulfonic acid (DNBS). After 6 and 21 days, the following parameters were assessed on paraffin sec-
tions from colonic samples: tissue injury and inflammatory infiltration by histology; collagen and elastic fibres by histochemistry; HuC/D, glial
fibrillar acidic protein (GFAP), proliferating cell nuclear antigen (PCNA), nestin, substance P (SP), von Willebrand factor, c-Kit and transmem-
brane 16A/Anoctamin1 (TMEM16A/ANO1) by immunohistochemistry. TMEM16A/ANO1 was also examined in isolated colonic smooth muscle
cells (ICSMCs). On day 6, inflammatory alterations and fibrosis were present in DNBS-treated rats; colonic wall thickening and fibrotic remodel-
ling were evident on day 21. Colitis was associated with both an increase in collagen fibres and a decrease in elastic fibres. Moreover, the neuro-
muscular compartment of inflamed colon displayed a significant decrease in neuron density and increase in GFAP/PCNA-positive glia of
myenteric ganglia, enhanced expression of neural SP, blood vessel remodelling, reduced c-Kit- and TMEM16A/ANO1-positive interstitial cells of
Cajal (ICCs), as well as an increase in TMEM16A/ANO1 expression in muscle tissues and ICSMCs. The present findings provide an integrated
view of the inflammatory and fibrotic processes occurring in the colonic neuromuscular compartment of rats with DNBS-induced colitis. These
morphological alterations may represent a suitable basis for understanding early pathophysiological events related to bowel inflammatory
fibrosis.
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Introduction
Inflammatory bowel diseases (IBDs) are complex pathological condi-
tions, which must be considered more than mere inflammatory reac-
tions. Indeed, because of their relapsing bouts and chronic course,
both Crohn’s disease and ulcerative colitis (UC) can progress to fibro-
sis, resulting in pharmacologically unmanageable alterations, which
can be resolved by disabling surgical resections [1, 2]. Although Cro-
hn’s disease is described as the IBD with the most fibrogenic trend,
an involvement of the whole intestinal wall can be appreciated also in
UC. Besides mucosal and submucosal lesions, UC patients display
also abnormalities of neuromuscular compartment, with alterations of
myenteric neuron/glia index and interstitial cells of Cajal (ICCs) [3–5].
Together with these abnormalities, the occurrence of fibrotic rear-
rangements in the colon of UC patients [6, 7] may represent the con-
sequence of a neglected problem, which may worsen the picture of
clinical symptoms [8].
Integrated data on the pathophysiology of inflammatory and fibro-
tic processes associated with human colitis are very scarce [1, 9].
Thus, suitable pre-clinical models of colitis, reflecting the histopatho-
logical features of human disease, can be useful for investigating the
pathogenic mechanisms leading to colitis and, thereby, to wall
remodelling [2]. Studies evaluating concomitantly both inflammatory
injuries and fibrotic rearrangements throughout the colonic wall
in the setting of colitis are also lacking. Indeed, a wide range of
morpho-functional parameters has been previously characterized in
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experimental colitis, but, in most cases, single parameters (e.g. either
extracellular matrix deposition, inflammatory indexes, or myenteric
neuron density) were examined with different methods (e.g. histo-
chemistry, immunofluorescence, molecular biology techniques), in
different samples (e.g. tissue sections, cultured cells), by different
authors and at different time-points. In this regard, besides the typical
histopathological lesions and collagen infiltration described in several
studies [10–15], scarce attention has been paid to rearrangements
occurring in the neuromuscular compartment, even though morpho-
logical alterations in this district may account for enteric dysmotility
associated with colonic inflammation.
Based on this background, an integrated assessment of a panel of
parameters, aimed at analysing, in the same model and at the same
time-points, a number of morphological and molecular changes
occurring in the neuromuscular compartment in the setting of colonic
inflammation, is expected to provide interesting insights into the
pathophysiological relationship between bowel inflammation and
fibrotic remodelling. Here, we propose that the model of colitis elic-
ited by 2,4-dinitrobenzenesulfonic (DNBS) in the rat [16], which
shares a number of pathological features with human IBDs, can be
suitable for investigating tissue remodelling associated with colonic
fibrosis, particularly at its early stages. To this aim, colonic samples
from DNBS-treated rats were examined for gross morphology and
histopathological lesions as well as for molecular and cellular markers
within the neuromuscular compartment.
Materials and methods
Induction of Colitis
Colitis was induced in male Sprague–Dawley rats (n = 20) by intrarectal
administration of 30 mg of DNBS [16]. The animals were housed and
handled in full accordance with the provisions of the European Commu-
nity Council Directive 86-609. Control rats (n = 10) were treated with
intrarectal saline. Animals were then evaluated on day 6 and 21 from
DNBS administration to assess the development of colonic inflammation
and fibrosis. At these time-points, animals were killed and the colon
was excised. Colonic inflammation was examined both macroscopically
and histologically [16].
Determination of tissue myeloperoxidase
Myeloperoxidase (MPO) levels in colonic tissues were determined as
previously reported [17], and taken as a quantitative index to estimate
Table 1 Antibodies used for immunohistochemistry and immunofluorescence
Primary antibodies Clone Host Dilution Code and source
c-Kit (CD117) PAb Rabbit 1:200 PC34; Calbiochem, Darmstadt, Germany
GFAP PAb Rabbit 1:100 Z0334; Dakocytomation
HuC/D MAb Mouse 1:250 A-21271; Molecular Probes
Nestin MAb Mouse 1:400 MAB353; Millipore
PCNA MAb Mouse 1:200 M 0879; Dakocytomation
SP MAb Rat 1:2000 Sc-21715; Santa Cruz Biotech
TMEM16A/ANO1 PAb Goat 1:100 Sc-69343; Santa Cruz Biotech
vWF PAb Rabbit 1:400 Ab6994; Abcam
Secondary antibodies Host Dilution Code and source
Anti-goat Alexa 568 Donkey 1:300 A-11057; Invitrogen, Eugene, OR, USA
Anti-mouse Alexa 488 Goat 1:300 A-11029; Invitrogen
Anti-rabbit Alexa 568 Goat 1:300 A-11011; Invitrogen
Biotinylated anti-goat IgG Rabbit 1:200 AP106B; Millipore
Biotinylated anti-mouse IgG* Goat 1:200 BA-9200; Vector Lab, Burlingame,
CA, USA
Biotinylated anti-rabbit IgG Goat 1:200 BA-1000; Vector Lab
*Revealed by streptavidin-conjugated Alexa 488 for immunofluorescence.
c-Kit (CD117) proto-oncogene, receptor-tyrosine kinase; GFAP, glial fibrillar acid protein; HuC/D, human neuronal proteins C and D; MAb,
monoclonal antibody; PAb, polyclonal antibody; PCNA, proliferating cell nuclear antigen; SP, Substance P; TMEM16A/ANO1, transmembrane16A/
anoctamin1; vWF, von Willebrand factor.
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the degree of mucosal infiltration by polymorphonuclear cells. The
results were expressed as ng of MPO per 100 mg of tissue.
Isolated colonic smooth muscle cells
Rat colonic smooth muscle cells (SMCs) were explanted from tunica
muscularis [18]. Briefly, colonic specimens from control and inflamed
animals were excised, washed several times with cold, sterile PBS, and
the muscular layers were separated from mucosa and submucosa. The
specimens of colonic muscular tissue were then minced and incubated
in complete DMEM growth medium (Gibco, Life Technology Italia, Mon-
za, Italy), under 5% CO2 at 37°C. Upon confluence, the explants were
dissociated by trypsin. Isolated colonic smooth muscle cells (ICSMCs)
were then maintained in DMEM 10% foetal bovine serum and used until
the fifth passage. Care was taken to verify that ICSMCs displayed and
Table 2 Systemic and tissue inflammatory parameters in colonic tissue samples collected from rats treated with DNBS or vehicle at day 6 or
21
Weight variation (%) Spleen weight (%) Macroscopic damage score MPO (ng/100 mg tissue)
Control day 6 +16  2.2 100  2.5 1.4  0.3 6.4  1.8
DNBS day 6 7  1.8* 128  4* 8.5  1.2* 28.8  5.2*
Control day 21 +38  3 100  4.5 1.3  0.2 5.2  2
DNBS day 21 +12  1.4*,† 138  3* 7.2  1.1* 16.4  3.8*,†
*P < 0.05 significant difference versus the respective group treated with vehicle.
†P < 0.05 significant difference versus DNBS day 6.
MPO: myeloperoxidase.
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Fig. 1 Histological appearance of haemat-
oxylin/eosin-stained full-thickness colonic
samples in control rats (A and B), or ani-
mals with DNBS-induced colitis at day 6
(C and D) and day 21 (E and F). The colo-
nic wall of controls shows normal mor-
phological features (A), with compact
myenteric ganglia, which are plenty of
neurons and glial cells (B). Colonic speci-
mens from rats with colitis are damaged
and thickened (C and E): myenteric gan-
glia appear to be vacuolized, with altered
cells (arrows), and infiltrated by eosinophil
granulocytes (D and F arrowheads), which
are widely present also throughout the
tunica muscularis; scale bars = 50 lm.
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maintained a SMC phenotype by immunostaining for standard markers
[19] (data not shown).
Immunoblotting in colonic tissues and ICSMCs
Colonic specimens were dissected to separate the mucosal/submuco-
sal layer from underlying neuromuscular tissues. Samples of colonic
muscular tissue or ICSMCs were homogenized in RIPA lysis buffer
(Cole Parmer homogenizer, Generalcontrol SpA, Milano, Italy). Homo-
genates were spun by centrifugation at 20,000 9 g for 15 min. at
4°C. Supernatants were then separated from pellets and stored at
80°C. Protein concentration was determined by the Bradford
method (Protein Assay Kit; Bio-Rad, Hercules, CA, USA). Equivalent
amounts of protein lysates (50 lg for tissues and 10 lg for ICSMCs)
were separated by 8% SDS-PAGE for immunoblotting. After transfer
onto a PVDF membrane, the blots were blocked and incubated
overnight with a rabbit anti-collagen I antibody (Ab34710; Abcam,
Cambridge, UK) or a goat anti-transmembrane 16A/Anoctamin1
(TMEM16A/ANO1) antibody (Table 1). After repeated washings with
TBS-T, appropriate secondary peroxidase-conjugated antibodies (Santa
Cruz Biotech, Santa Cruz, CA, USA) were added for 1 hr at room
temperature. Immunoreactive bands were then visualized by incuba-
tion with chemiluminescent reagents (Immobilon reagent; Millipore,
Billerica, MA, USA), and examined by Kodak Image Station 440 for
signal detection. To ensure equal sample loading, blots were stripped
and reprobed for determination of b-actin by a specific antibody
(P5747; Sigma-Aldrich, Milan, Italy).
B b
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A a Fig. 2 Representative photomicrographs of
full-thickness colon showing the distribu-
tion pattern of Sirius Red-stained collagen
fibres and Fast Green-stained non-collagen
proteins in control rats (A, a inset) or ani-
mals with DNBS-induced colitis at day 6
(B, b inset) and day 21 (C, c inset). Colla-
gen deposition increases at day 6 and day
21, as compared with controls. (SM, sub-
mucosal layer; CM and LM, circular and
longitudinal muscle respectively; S, ser-
osa); scale bars = 50 lm. Quantitative
estimations of collagen and non-collagen
proteins were performed by image analy-
sis and expressed as percentage of posi-
tive pixels (PPP) calculated on the whole
colonic wall (D) or tunica muscularis (E)
tissue area examined. Column graphs dis-
play the mean values of PPP  SD
obtained from eight rats. a,bP ≤ 0.05 ver-
sus respective controls, cP ≤ 0.05 versus
DNBS day 6.
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Histology, histochemistry, immunohistochemistry
and confocal microscopy
Formalin-fixed full-thickness samples were serially cross-sectioned
(10 lm-thick). Sections were processed for haematoxylin/eosin stain-
ing, histochemical staining for collagen and elastic fibres, and immuno-
staining with various antibodies and reagents (Table 1). To measure the
thickness of tunica muscularis, a morphometric analysis was carried
out from images captured with 209 objective using the Image Analysis
System ‘L.A.S. software v.4’ (Leica Microsystems, Cambridge, UK). Tis-
sue collagen deposition was evaluated by histochemical staining with
Sirius Red and Fast Green in saturated picric acid solution [11]: colla-
gen fibres (red) and cellular, non-collagen proteins (green) were quanti-
tatively estimated within the respective colonic area (whole wall or
tunica muscularis). Elastic fibres were stained in black with orcein in
70% ethanol acidic solution.
To perform immunohistochemistry, sections were processed as pre-
viously described [5] and incubated overnight at 4°C with primary anti-
bodies, with the purpose of detecting myenteric neurons and glia, ICCs,
proliferating cells and new vessels (Table 1). Slides were then exposed
to biotinylated immunoglobulins, peroxidase-labelled streptavidin
Fig. 3Western blot analysis of collagen I in the colonic neuromuscular
layer of control and DNBS-treated rats. Tissue specimens were obtained
from control rats as well as animals with colitis after 6 days (DNBS day
6) or 21 days (DNBS day 21) from treatment with DNBS. The column
graph displays mean values of densitometric analysis SD obtained
from six animals. aP ≤ 0.05 versus controls.
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Fig. 4 Representative photomicrographs of
full-thickness colon displaying the distri-
bution pattern of orcein-stained elastic
fibres in control rats (A and B) or animals
with DNBS-induced colitis at day 6 (C and
D) and day 21 (E and F). Elastic fibres
decrease, mainly along the myenteric
ridge, by day 6, and return to a normal
pattern by day 21; scale bars = 50 lm.
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complex and 3.30-diaminobenzidine tetrahydrochloride (DakoCytomation,
Glostrup, Denmark). Sections were examined by a Leica DMRB light
microscope, and representative photomicrographs were taken by a
DFC480 digital camera (Leica Microsystems).
Double immunofluorescence was carried out with primary antibodies
against glial fibrillar acidic protein (GFAP) combined with proliferating
cell nuclear antigen (PCNA) or nestin, and von Willebrand Factor (vWF)
combined with nestin [20]. Briefly, sections were sequentially incubated
with: 0.5% Triton X-100 (Merck KGaA, Darmstadt, Germany) in PBS
solution, Protein Block Serum Free (Dako Cytomation, Glostrup, Den-
mark); combined primary antibodies (overnight at 4°C), revealed by
appropriate fluorophore-conjugated secondary antibody or biotinylated
secondary antibody followed by fluorophore-conjugated streptavidin;
nuclear counterstaining with TO-PRO3 (Molecular Probes, Eugene, OR,
USA). Stainings were examined under a Leica TCS SP5 confocal laser-
scanning microscope (Leica Microsystems, Mannheim, Germany) using
a sequential scan procedure. Confocal images were taken at 250–
500 nm intervals through the z-axis of sections, by means of 409 and
639 oil lenses. Z-stacks of serial optical planes were analysed by
confocal software (Multicolor Package; Leica Microsystems).
Negative controls were obtained by omitting primary antibodies. Tis-
sue positive (liver) and negative (cartilage) controls were employed to
validate the specificity of TMEM16A/ANO1 antibodies (Fig. 12).
Image analysis and statistics
Histochemical and immunohistochemical findings were quantitatively
estimated by two blind investigators [5]. Briefly, 5 randomly selected
microscopic fields from 3 non-adjacent sections were analysed for
each animal (n = 6–8) and evaluated by the Image Analysis System
‘L.A.S. software v.4’. Positive areas were expressed as percentage of
the total tissue area examined (percentage positive pixels, PPP). Neu-
ronal density was estimated as neuron number within ganglionic area
by HuC/D immunostaining of nuclei and/or perikarya [21]. To quantify
the proliferation of glial cells, the percentage of GFAP-positive glia
which displayed PCNA-labelled nuclei was determined [22]. Data are
given as mean  SD. Student’s t-test for unpaired data (two-tailed)
was performed to assess statistical differences between groups. A
P ≤ 0.05 was considered significant. For histochemistry and immuno-
histochemistry, quantitative variations were expressed as fold changes,
which were calculated as the ratio of the final value over the initial
value. For immunoblotting assays, quantitative determination of band
intensity was calculated as the ratio between the protein of interest
and b-actin.
Results
Evaluation of colonic inflammation
At day 6 after DNBS administration, there was a significant decrease
in bodyweight, and increments of spleen weight and bowel inflamma-
tory parameters (macroscopic damage and MPO levels). Likewise, at
day 21, the bodyweight gain was lower, while systemic and tissue
inflammatory parameters were significantly increased in comparison
with controls, although MPO drifted towards a recovery as compared
with DNBS at day 6 (Table 2).
Histology
Colonic samples from controls displayed a normal tissue architec-
ture, with myenteric ganglia filled of neurons and glial cells
(Fig. 1). At day 6 after DNBS, transmural lesions, consistent with
colitis, were detected: ulcerated mucosa, infiltrated tunica submu-
cosa, thickened tunica muscularis, which increased by 3.4-fold
(282.00  0.49) versus control (83.65  0.23, P ≤ 0.001), along
with infiltrations with macrophages, neutrophils and eosinophils.
Myenteric ganglia were infiltrated by eosinophils, and displayed cell
A
B
C
D
Fig. 5 HuC/D-immunostained myenteric ganglia in cross-sections of rat
colonic specimens. In normal ganglia, neurons are abundant and mark-
edly HuC/D immunoreactive (A). At day 6 and 21 from DNBS adminis-
tration, there is a decrease in both neuron density and their
immunoreactivity (B and C respectively), even if at day 21 the morphol-
ogy of ganglia is more similar to that of controls (C); scale
bar = 50 lm. (D) The column graph displays mean values of neuron
density (neurons/mm2) SD obtained from six rats. aP ≤ 0.05 versus
controls.
490 ª 2014 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
loss and lacunar spaces (Fig. 1). At day 21, the colonic wall was
still thickened, with a 3.6-fold increase of tunica muscularis
(300.95  0.87, P ≤ 0.001) versus controls, and affected by resid-
ual leucocyte infiltration, which consisted mainly of eosinophils.
Myenteric ganglia still displayed appreciable alterations (vacuoles
and eosinophils) (Fig. 1).
Tissue distribution of collagen and elastin
The distribution pattern of collagen underwent considerable changes
in DNBS-treated animals (Fig. 2). Control colon displayed transmural
Sirius Red-stained collagen proteins. After DNBS administration, col-
lagen deposition within the whole colonic wall increased significantly
at both day 6 and day 21 (Fig. 2), displaying a scattered distribution
within tunica submucosa and muscularis. When the analysis was
focused on tunica muscularis, collagen fibres were found to be
arranged into thick bundles, mainly along myenteric ridge and longi-
tudinal layer, and significantly increased in comparison with controls
(Fig. 2E). These increments were consistent with data from immuno-
blot analysis of collagen I (Fig. 3).
The distribution pattern of elastic fibres (Fig. 4), which were
detected throughout the whole thickness of control colon
(4.09  1.68; n = 6), with a predominance in vessel walls, was
markedly altered in animals with DNBS-induced colitis. In particular,
at day 6, elastic fibres were decreased by 4.5-fold (0.91  0.25;
P ≤ 0.05; n = 6), while they recovered at day 21 (3.81  0.67;
n = 6).
B
DC
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Fig. 6 Representative pictures of GFAP im-
munostaining in colonic tunica muscularis
and myenteric ganglia from control rats
(A and B) or animals with DNBS-induced
colitis at day 6 (C and D) and day 21 (E
and F). By comparison with controls, at
day 6 GFAP expression significantly
increases in muscle layers and myenteric
ganglia; scale bars = 50 lm. Quantitative
estimation of GFAP expression was
obtained by image analysis and expressed
as percentage of positive pixels (PPP) cal-
culated on the whole tunica muscularis
(G) or myenteric ganglionic (H) area
examined. Column graphs display mean
values of PPP SD obtained from six
rats. aP ≤ 0.05 versus controls; bP ≤ 0.05
versus DNBS day 6.
ª 2014 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
491
J. Cell. Mol. Med. Vol 19, No 2, 2015
Immunostaining
HuC/D, GFAP and PCNA
Enteric neurons were detected by cytoplasmic and/or nuclear HuC/D
immunostaining, as observed in control colon (Fig. 5). At day 6, my-
enteric neurons displayed an inhomogeneous HuC/D staining and
several cytoplasmic vacuoles, whereas at day 21, neurons appeared
smaller than controls, displaying a scant cytoplasmic HuC/D expres-
sion. At day 6 and 21, the number of myenteric HuC/D-positive neu-
rons in DNBS-treated rats was reduced by 1.6- and 1.1-fold
respectively.
Glial cells were identified by their reactivity to anti-GFAP immuno-
staining (Fig. 6). At day 6, in DNBS-treated rats, the amount of GFAP
staining in inflamed colon increased within the muscle layers (6.7-
fold), which appeared rich in fibroblast-like shaped GFAP-positive
cells, as well as in myenteric ganglia (1.2-fold). In these ganglia, sev-
eral GFAP-positive glial cells showed PCNA-positive nuclei (43%),
consistent with a glial proliferating feature, which was maintained at
day 21 (24%) (Fig. 7). At day 21, the GFAP immunostaining value of
inflamed colon was 0.44  0.13 versus control 0.23  0.09
(P < 0.05; n = 6) in muscle layers and 27.75  8.11 (n = 6) versus
control 26.32  1.89 (n = 6) in myenteric ganglia, thus remaining
significantly high only within the tunica muscularis (1.9-fold), but not
in the ganglionic area (1.0-fold; Fig. 6).
Nestin, GFAP and vWF
DNBS-treated animals displayed nestin staining in myenteric ganglia,
which was co-localized with GFAP, particularly at day 6 (Fig. 8). The
examination of vessel network, performed by double vWF/nestin im-
munolabelling, highlighted the presence of newly formed vWF/nestin-
positive microvessels in the tunica muscularis at day 6 and 21 (Fig. 9).
Substance P
In control colon, substance P (SP) immunoreactivity was found in
nerve fibres of tunica muscularis and myenteric ganglia (Fig. 10). In
A B
D
G
C
E F
Fig. 7 Representative pictures of PCNA immunostaining in colonic tunica muscularis and myenteric ganglia from control rats (A) or animals with
DNBS-induced colitis at day 6 (C) and day 21 (E). By comparison with controls, on day 6 PCNA positivity is expressed mainly along the myenteric
ridge in the nuclei of small ganglionic and muscle cells (arrows and arrowheads respectively), while it decreases on day 21. Confocal microscopy
representative images of PCNA/GFAP double immunolabelled sections show GFAP-positive glial cells with PCNA-nuclei at day 6 and 21 (arrows; D
and G) compared with ganglia from control rats (B); scale bars = 50 lm. (F) The column graph displays mean values of the percentage of GFAP-
positive glial cells with PCNA-labelled nuclei over GFAP-positive glia of myenteric ganglia SD obtained from six rats. aP ≤ 0.05 versus controls.
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the colon from DNBS-treated rats, the density of SP-positive nerve
fibres increased both in muscle layers and myenteric ganglia. At day
6 and 21, SP expression in the inflamed colon increased by 1.8- and
2.7-fold in the tunica muscularis, and by 3.4- and 4.6-fold in the
myenteric ganglia respectively.
c-Kit and TMEM16A/ANO1
In control colon, ICCs were identified as spindle-shaped c-Kit-positive
and TMEM16A/ANO1-positive cells, endowed with long bipolar pro-
cesses, mostly running parallel to the axis of SMCs in the tunica
muscularis, as well as along submucosal and myenteric ridges
(Figs 11 and 12). In DNBS-treated rats, the morphological features
and distribution patterns of ICCs were markedly modified, being
maintained only the ICC network around myenteric ganglia. Of note,
in inflamed colon, TMEM16A/ANO1 was widely expressed within
SMCs of tunica muscularis. This finding was confirmed by western
blot analysis of colonic tissues, which showed an increased expres-
sion of TMEM16A/ANO1 (Fig. 12G), and supported further by studies
A
B
C
Fig. 8 Confocal microscopy representative images of GFAP/nestin
double-immunolabelled myenteric ganglia from control rats (A) and
animals with DNBS-induced colitis on day 6 and 21 (B and C). In the
myenteric ganglia of inflamed rats, glial cells display nestin immunore-
activity, which co-localizes with GFAP in bodies and processes at both
day 6 (B, inset) and 21 (C, inset); scale bar = 50 lm.
A
B
C
Fig. 9 Confocal microscopy representative images of nestin/vWF immu-
nolabelling of tunica muscularis from controls and animals with colitis
at day 6 and day 21. Inflamed colon (B and C) shows vWF-positive
endothelial cells with multiple points of nestin/vWF colocalization on the
endothelial profiles (arrows) compared with controls (A); scale
bar = 50 lm.
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on ICSMCs from rats with colitis at day 6, which displayed high levels
of TMEM16A/ANO1 expression (Fig. 13).
Discussion
Cellular and molecular events occurring in colonic inflammation rep-
resent an interesting field of investigation, in view of their important
implications for related bowel dysfunctions [9]. With regard to intesti-
nal dysmotility, which accompanies both inflammatory and fibrotic
processes, the pathophysiological bases probably descend from mor-
phological and/or electrophysiological alterations in the neuromuscu-
lar compartment, as pointed out by previous reviews [23, 24].
However, a combined evaluation of both bowel inflammation and
fibrosis, with particular regard for the neuromuscular district, is lack-
ing. Therefore, the present study was designed to assess a number of
morphological and pathophysiological aspects in the same model of
colitis, to obtain an integrated view of changes associated with
inflammation and fibrosis, and gain insight into their impact on colo-
nic remodelling. Particular attention was paid to the cellular elements
involved in the control of enteric motility.
Although colitis induced by 2,4,6-trinitrobenzenesulfonic acid
(TNBS) in mice has been previously employed for investigations on
bowel inflammatory fibrosis [1, 10, 15], we selected the DNBS rat
model of colitis for different reasons: (i) DNBS is less aggressive than
TNBS against the mucosal layer [25]; (ii) rats develop a maximal
degree of colonic inflammation/fibrosis earlier (usually by day 6 [26])
than mice, which are relatively resistant to the induction of fibrosis
A B
C D
E F
G H
Fig. 10 Representative pictures of SP im-
munostaining in colonic tunica muscularis
and myenteric ganglia from control rats
(A and B) or animals with DNBS-induced
colitis at day 6 (C and D) and day 21 (E
and F). Note the increase in SP positivity
within the muscle layers and myenteric
ganglia over the two time-points; scale
bars = 50 lm. (G and H) Quantitative
estimation of SP expression was obtained
by image analysis and expressed as per-
centage of positive pixels (PPP) calculated
on the whole tunica muscularis (G) or my-
enteric ganglionic (H) area examined. Col-
umn graphs show mean values of PPP 
SD obtained from six rats. aP ≤ 0.05 ver-
sus controls; bP ≤ 0.05 versus DNBS day
6.
494 ª 2014 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
(8–12 weeks [27]); (iii) DNBS-induced inflammatory lesions are con-
sistent with those observed in human IBDs [28].
In our experiments, the wall of inflamed colon from DNBS-trea-
ted animals was thickened. At day 6, this picture was concomitant
with inflammatory mucosal/submucosal lesions, which were rich in
cellular infiltrates (eosinophils, neutrophils), as also documented by
the increase in tissue MPO, and a transmural deposition of collagen
fibres. These alterations were associated with bodyweight loss and
spleen weight increase, in line with previous reports [10, 16, 29,
30]. On day 21, besides a decrease in the severity of inflammation,
an increased deposition of connective fibres persisted within the
tunica submucosa and muscularis. Accordingly, increased pro-collagen
mRNA expression and collagen protein deposition have been
reported to occur over the course of fibrotic processes associated
with experimental colitis [14, 31–33]. Furthermore, in our experi-
ments, muscle thickening in the inflamed colon was concomitant
with the presence of PCNA-labelled nuclei in the tunica muscularis
and an increment of non-collagen components, suggesting a hyper-
plastic reaction of colonic SMCs, in accordance with previous stud-
ies in rats with TNBS-induced colitis [10, 11]. In the present study,
colitis was associated also with a loss of elastic fibres, which
recovered on day 21. This derangement of collagen/elastin network
might well contribute to bowel motor dysfunctions, contributing to
weight loss, which is a hallmark of animals with colitis [2, 15].
Moreover, the decreased density of myenteric HuC/D-positive neu-
rons, as observed in DNBS-treated rats, in accordance with previ-
ous studies [34, 35], may contribute to colonic motor dysfunctions
as well. Of note, such a loss of myenteric neurons appears to
occur at an early stage of bowel inflammation, and it is supported
by an early activation of pro-apoptotic signals [36], with particular
regard for caspase-3 [28].
When considering glial cells, the examination of three distinct
markers (GFAP, PCNA and nestin) allowed us to observe an activa-
tion (GFAP expression increase) and proliferation (PCNA-positive
nuclei) of myenteric glial cells in the inflamed colon at day 6 and
day 21. Our results expand previous data documenting a glial rear-
rangement under inflammatory conditions. In particular, activation
was observed in cultured rat and human enteric glial cells, which
expressed increased GFAP levels, but no increase in proliferation
rate, in response to inflammatory cytokines [37, 38]. By contrast,
there was evidence of mitotic activity in myenteric glia under
TNBS-induced ileitis [39] and other models of bowel inflammation
[40]. In addition, the present up-regulation of nestin in activated
GFAP-positive myenteric glial cells is consistent with previous
observations showing an increased expression of GFAP and nestin
in reactive astrocytes of central nervous system under pathological
conditions [41, 42]. Of note, nestin is regarded as a marker of mul-
tilineage progenitor cells and an index of potential regenerative
activity [43, 44]. On this basis, the presence of GFAP/PCNA/nestin-
positive cells in myenteric ganglia, as observed in our study, sug-
gests a recruitment of activated glial cells with stem potential in
the myenteric ganglia of inflamed colon.
In the neuromuscular compartment of inflamed colon, we noted a
number of vWF/nestin-positive neovessels and sprouting. Neoangio-
genic processes have been described in experimental colitis [35, 45,
46] and under fibrotic conditions associated with nestin-positive vas-
cular endothelium [47–49]. The detection of neovessels during
inflammation is of great interest, as they are likely to participate in the
A B C
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Fig. 11 Representative pictures of c-Kit
immunostaining in the colonic tunica
muscularis of control rats (A), or animals
with DNBS-induced colitis at day 6 (B)
and day 21 (C). Arrowheads, arrows and
asterisks highlight ICCs of submucosal
plexus (SMP), myenteric plexus (MP) and
intramuscular ICCs respectively. At day 6,
a derangement of ICCs is evident, with a
partial recovery at day 21; scale
bars = 50 lm.
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Fig. 12 Representative pictures of TMEM16A/ANO1 immunostaining in the colonic tunica muscularis of control rats (A) or animals with DNBS-
induced colitis at day 6 (B) and day 21 (C). ICCs of myenteric plexus (MP) and intramuscular ICCs (arrows and arrowheads respectively) of control
colon are immunostained for TMEM16A/ANO1. In the inflamed colon, immunopositive smooth muscle cells are present (B and C; asterisks). Zoomed
insets (a, b1, b2, c1, c2) on myenteric ridge and circular muscle. Negative control colon (D). Positive (E, liver) and negative (F, cartilage) control tis-
sues; scale bars = 50 lm. (G) Western blot analysis of TMEM16A/ANO1 in the colonic neuromuscular layer of control and DNBS-treated rats. Colo-
nic specimens were obtained from control rats as well as animals with colitis after 6 days (DNBS day 6) or 21 days (DNBS day 21) from treatment
with DNBS. The column graph displays mean values of densitometric analysis SD obtained from six animals. aP ≤ 0.05 versus controls.
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initiation of fibrotic remodelling. Indeed, pericytes and endothelium
can be regarded as precursors of activated myofibroblasts, and endo-
thelial-to-mesenchymal transition is considered as a relevant step in
the pathogenesis of fibrosis [45, 46]. Highly pertaining to this context
are also recent findings, supporting the concept that telocytes, dis-
playing immunoreactivity for platelet-derived growth factor receptor
b, contribute to neoangiogenesis in skeletal muscles [50] and might
be implicated in vascular fibrogenesis associated with bowel inflam-
mation as well.
The neuromuscular compartment of inflamed colon was found
to express increased levels of SP fibres. This increment was most
evident in myenteric ganglia, in accordance with previous observa-
tions [51–54]. SP is involved in the control of enteric motility and
intercellular communications between myenteric neurons [55, 56].
Of interest, glial cells, besides their neurotrophic action, play also
neuromodulatory actions on SP neurons, as a result of their ability
of increasing neuronal survival and promoting SP expression and
release [56]. Furthermore, SP is considered as an important factor
mediating vasodilation and release of inflammatory mediators, thus
regulating the permeability of enteric vessels [53]. Interestingly, in
human UC elevated levels of SP and its receptors as well as
SP-induced leucocyte chemotaxis have been reported [53, 57].
This panel of activities can qualify SP as a significant factor pro-
moting intestinal fibrogenesis, as suggested also by other studies
[51, 58].
In the present study, the normal colonic neuromuscular compart-
ment displayed appreciable immunoreactivity for c-Kit and
TMEM16A/ANO1. In our hands, TMEM16A/ANO1 was found to be a
sensitive marker of ICCs, being expressed in a higher proportion of
ICCs in the submucosal and myenteric plexus, as compared with
c-Kit. However, the distribution pattern of TMEM16A/ANO1 was found
to be altered in the inflamed colon. In particular, in parallel with a loss
of TMEM16A/ANO1-positive ICCs, we detected TMEM16A/ANO1 in
muscle layers and ICSMCs, by both immunostaining and immuno-
blotting. This finding appears to be original in the context of bowel
inflammation, but it is not surprising according to current literature.
Indeed, TMEM16A/ANO1 is a Ca+-activated chloride channel, cur-
rently regarded as a specific marker for ICCs [59]. However, it has
been reported that other cells equipped with Ca+-activated chloride
currents may express TMEM16A/ANO1 [60–62], which has been also
found in SMCs of several organ systems [61, 63–67]. In addition, ele-
vated levels of TMEM16A/ANO1 staining in SMCs have been reported
in models of experimental disease, such as pulmonary hypertension
[68] and chronic asthma [69]. Thus, considering the wide contribu-
tion of TMEM16A/ANO1 to the myogenic activity of vascular SMCs
[63, 70], its up-regulation in SMCs of inflamed colon, together with
the derangement of ICC network, as observed in our study, might
contribute to enteric motor dysfunctions associated with bowel
inflammation [24]. Taken together, these considerations open new
pathophysiological and therapeutic perspectives in the field of IBDs.
Indeed, therapeutic interventions targeted on Ca+-activated chloride
channels have been recently proposed for several diseases (e.g. acti-
vators for cystic fibrosis, and inhibitors for hypertension, asthma, and
secretory diarrhoea) [71].
In conclusion, the variety of markers and cells examined in the
present study provide an integrated view of the impact of inflamma-
tory and fibrotic processes on colonic neuromuscular compartment.
According to our findings, the rat model of DNBS-induced colitis dis-
plays significant processes of colonic remodelling, consisting not
A
B
C
Fig. 13 Isolated colonic smooth muscle cells (ICSMCs) obtained from
control or inflamed (DNBS day 6) rats (A and B respectively) and im-
munolabelled for TMEM16A/ANO1; scale bar = 50 lm. (C) Western blot
analysis of TMEM16A/ANO1 in ICSMCs from control and DNBS-treated
rats (DNBS day 6). The column graph displays mean values of densito-
metric analysis SD obtained from three animals. aP ≤ 0.05 versus
controls.
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only in collagen deposition and wall thickening, but also in specific
cellular alterations of the neuromuscular units, such as myenteric
neurons, glial cells, ICCs and SMCs.
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